Reviewed by the Celnovix Editorial Team
Last reviewed: September 2026
Muscle health is becoming one of the most interesting areas of Urolithin A research.
The reason is not that Urolithin A directly builds muscle like resistance training.
Instead, researchers are interested in something deeper:
the relationship between aging muscle, mitochondria and cellular quality control.
Urolithin A is a gut microbiome-derived metabolite that has been studied for its effects on mitophagy—the cellular process involved in identifying and recycling damaged or dysfunctional mitochondria.
Because skeletal muscle has high energy demands and mitochondrial function can change with age, researchers have asked whether Urolithin A supplementation might support:
- Muscle endurance
- Muscle strength
- Walking capacity
- Mitochondrial health
- Physical performance
- Healthy muscle aging
Several randomized human trials have now investigated these questions.
And in July 2026, researchers published a new systematic review and meta-analysis combining the available randomized controlled trial evidence.
The result is more nuanced than many supplement claims suggest.
Some studies have reported promising improvements in selected muscle outcomes.
But the total human evidence remains:
small, heterogeneous and not yet definitive.
Urolithin A and Muscle Health: Key Takeaways
- Urolithin A is primarily studied for mitophagy and mitochondrial quality control, not as a direct muscle-building compound.
- A 2026 systematic review identified five randomized controlled trials involving 236 participants.
- The pooled effect on the six-minute walk test favored Urolithin A by approximately 17 meters, but the result was not statistically significant.
- The certainty of that pooled evidence was rated low using GRADE.
- One trial in adults aged 65–90 found improvements in hand and leg muscle endurance.
- A trial in middle-aged adults reported improvements in selected measures of muscle strength.
- That same middle-aged trial did not significantly improve its primary endpoint of peak power output.
- Human studies have reported changes in mitochondrial-related biomarkers.
- Biomarker changes do not automatically prove better muscle function.
- Urolithin A has not been proven to directly increase muscle mass.
- Urolithin A is not an established treatment for sarcopenia.
- Resistance training, adequate protein and sufficient energy intake remain much better established for maintaining muscle with age.
Why Are Scientists Studying Urolithin A for Muscle Health?
To understand the interest in Urolithin A, it helps to understand what happens inside muscle cells.
Skeletal muscle requires enormous amounts of energy.
Much of that energy depends on:
mitochondria.
Mitochondria help cells convert nutrients into usable cellular energy.
But mitochondria are not permanent structures.
They are continuously:
- Produced
- Remodeled
- Repaired
- Recycled
Damaged or dysfunctional mitochondria need to be removed.
One of the processes involved in this quality-control system is:
mitophagy.
What Is Mitophagy?
Mitophagy is a selective form of autophagy.
Its role is to help cells identify and remove mitochondria that are:
- Damaged
- Dysfunctional
- No longer operating efficiently
The cellular components can then be recycled.
This helps maintain a healthier mitochondrial network.
A simplified model looks like this:
Mitochondrial damage
↓
Cellular recognition
↓
Mitophagy
↓
Removal and recycling
↓
Mitochondrial quality control
Urolithin A became scientifically interesting because preclinical studies suggested that it could stimulate pathways associated with mitophagy.
Why Does Mitophagy Matter for Aging Muscle?
Muscle aging is not caused by one mechanism.
It can involve changes in:
- Muscle protein synthesis
- Hormonal signaling
- Physical activity
- Motor neurons
- Inflammation
- Mitochondrial function
- Nutrient intake
- Recovery
- Cellular quality control
Mitochondrial dysfunction is one part of this larger picture.
As people age, the ability to maintain mitochondrial quality may become less efficient.
That can theoretically influence:
- Energy production
- Muscle fatigue
- Exercise capacity
- Recovery
This is where Urolithin A enters the research conversation.
But there is an important distinction:
A compound that affects mitochondrial biology does not automatically preserve muscle mass or prevent age-related muscle decline.
Human outcomes still need to be demonstrated.
What Does the Latest 2026 Research Say?
In July 2026, researchers published a systematic review and meta-analysis specifically examining:
Urolithin A supplementation and human muscle-health outcomes.
The researchers searched randomized controlled trials published through December 2025.
They identified:
5 randomized controlled trials
involving:
236 participants.
The studies differed substantially in:
- Participant age
- Health status
- Urolithin A dose
- Study duration
- Muscle outcomes
- Mitochondrial measurements
Because of this heterogeneity, most outcomes could not be pooled statistically.
Only one outcome had enough comparable data for quantitative meta-analysis:
the six-minute walk test.
View the 2026 systematic review on PubMed
What Is the Six-Minute Walk Test?
The six-minute walk test—often abbreviated:
6MWT
—is a standardized test measuring how far someone can walk in six minutes.
It provides information about:
- Functional exercise capacity
- Mobility
- Endurance
It is commonly used in clinical research involving:
- Older adults
- Cardiopulmonary disease
- Physical function
- Rehabilitation
Two Urolithin A trials reported comparable six-minute walk outcomes.
Did Urolithin A Improve Walking Distance?
The 2026 meta-analysis calculated a pooled mean difference of:
+17.03 meters
favoring Urolithin A.
The 95% confidence interval was:
−5.33 to +39.40 meters.
The P value was:
0.135.
This means the pooled result was:
not statistically significant.
The confidence interval crossed zero.
Therefore, the evidence does not allow us to confidently conclude that Urolithin A improves six-minute walking distance.
Why the +17 Meter Result Still Matters
A nonsignificant result does not automatically mean:
“Urolithin A does nothing.”
The estimated effect favored Urolithin A.
But uncertainty around the estimate was too large to rule out:
- Little or no effect
- A potentially meaningful benefit
This is precisely why larger trials are needed.
The correct interpretation is:
The current evidence points in a favorable direction, but it is not sufficiently precise or robust to establish an effect.
How Strong Is the Evidence?
The researchers used:
GRADE
to assess certainty.
GRADE considers factors such as:
- Study limitations
- Consistency
- Precision
- Directness
- Publication bias
The certainty of evidence for the six-minute walk outcome was rated:
LOW.
That is important.
It means future high-quality studies could substantially change the estimate.
What About Muscle Strength?
The evidence becomes more interesting—but also more complicated.
A randomized controlled trial published in 2022 studied:
88 untrained, overweight middle-aged adults.
Participants were assigned to:
- Placebo
- 500 mg/day Urolithin A
- 1,000 mg/day Urolithin A
for:
four months.
Researchers measured:
- Muscle strength
- Peak power
- VO₂-related exercise performance
- Six-minute walking distance
- Mitochondrial biomarkers
Did Urolithin A Increase Muscle Strength?
The middle-aged-adult trial reported improvements in selected muscle-strength outcomes.
The researchers described approximately:
12% improvements in muscle strength
with Urolithin A supplementation.
That sounds impressive.
But the context matters.
The study included multiple endpoints.
And its:
primary endpoint
was not muscle strength.
What Was the Primary Endpoint?
The study’s primary endpoint was:
peak power output.
Urolithin A did not produce a statistically significant improvement in that primary endpoint.
That distinction is important.
Clinical trials often measure many outcomes.
A study can therefore show:
- Positive secondary outcomes
while:
- Missing its primary endpoint
Both pieces of information should be reported.
Why Primary Endpoints Matter
The primary endpoint is usually the outcome a clinical trial is specifically designed and statistically powered to evaluate.
Secondary endpoints provide valuable information.
But when a trial:
misses its primary endpoint
while several secondary outcomes look positive, interpretation should remain cautious.
This does not make the secondary results meaningless.
It means they need:
independent replication.
What About Muscle Endurance?
This is another promising area.
A randomized clinical trial published in JAMA Network Open studied:
66 adults aged 65–90.
Participants received:
1,000 mg/day Urolithin A
or placebo for:
four months.
Researchers measured:
- Six-minute walking distance
- Muscle endurance
- Maximal mitochondrial ATP production
- Blood biomarkers
Did Urolithin A Improve Muscle Endurance?
Yes—selected endurance outcomes improved.
Compared with placebo, participants receiving Urolithin A showed improvements in:
- Hand muscle endurance
- Leg muscle endurance
The tests measured the number of muscle contractions participants could perform before fatigue.
This suggests a potential effect on:
fatigue resistance.
That is different from:
- Increasing muscle size
- Increasing maximal strength
- Building new muscle tissue
Muscle Endurance Is Not the Same as Muscle Mass
This distinction matters for SEO and for consumers.
Muscle Mass
Refers to:
the amount of muscle tissue.
Muscle Strength
Refers to:
how much force muscle can generate.
Muscle Power
Combines:
force and speed.
Muscle Endurance
Refers to:
how long muscle can continue performing before fatigue.
Urolithin A research has shown more interesting signals around:
endurance and mitochondrial biology
than around directly increasing muscle mass.
Does Urolithin A Build Muscle?
Current human evidence does not establish Urolithin A as a muscle-building supplement.
There is not strong evidence showing that supplementation alone significantly increases:
- Skeletal muscle mass
- Lean body mass
- Muscle cross-sectional area
- Hypertrophy
Therefore statements such as:
“Urolithin A builds muscle”
go beyond current human evidence.
Is Urolithin A Like Creatine?
No.
The evidence base and mechanisms are different.
Creatine
Has extensive research involving:
- Strength
- Power
- Resistance training
- Lean tissue
especially when combined with exercise.
Urolithin A
Is being studied primarily around:
- Mitophagy
- Mitochondrial quality control
- Muscle endurance
- Healthy muscle aging
For healthy muscle aging:
Creatine for Healthy Muscle Aging: Benefits, Dosage and Safety
The two compounds should not be treated as interchangeable.
Does Urolithin A Improve Exercise Performance?
The answer depends on what type of performance is measured.
The middle-aged-adult trial reported favorable findings in:
- Selected muscle-strength measures
- Aerobic endurance-related measures
- Six-minute walk performance
But:
peak power output—the primary endpoint—did not improve significantly.
The older-adult trial reported:
- Improved muscle endurance
but did not demonstrate significant improvement in its primary:
six-minute walk distance
outcome.
So:
Human performance findings are promising but inconsistent across endpoints.
Does Urolithin A Improve VO₂ Max?
The middle-aged trial reported improvements in aerobic endurance measures involving:
peak oxygen consumption.
This is scientifically interesting.
But a single relatively small trial is not enough to establish Urolithin A as a proven aerobic-performance supplement.
The 2026 systematic review therefore classified non-6MWT outcomes such as aerobic capacity as:
exploratory signals rather than reproducible evidence of efficacy.
What About Mitochondrial Health?
This is arguably the strongest mechanistic area of Urolithin A research.
The first human clinical trial found that four weeks of:
- 500 mg/day
- 1,000 mg/day
Urolithin A altered:
- Plasma acylcarnitines
- Skeletal-muscle mitochondrial gene expression
in older adults.
View the first-in-human trial on PubMed
These findings supported biological activity in humans.
But:
mitochondrial biomarkers are not the same as physical function.
What Are Acylcarnitines?
Acylcarnitines are metabolites related to:
- Fatty-acid metabolism
- Mitochondrial substrate processing
Elevated patterns can sometimes reflect incomplete fatty-acid oxidation or metabolic inefficiency.
Several Urolithin A studies reported reductions in selected plasma acylcarnitines.
Researchers have interpreted these changes as potentially consistent with:
improved mitochondrial efficiency.
But acylcarnitine changes are still:
biomarkers.
They do not directly prove:
- More muscle
- Greater strength
- Better mobility
- Longer lifespan
Does Urolithin A Increase Mitochondria?
This is another place where marketing language can become misleading.
Urolithin A is primarily studied as a:
mitophagy-related compound.
Mitophagy involves mitochondrial quality control.
That is not identical to:
mitochondrial biogenesis
—the production of new mitochondria.
A 2024 systematic review did not find consistent evidence that Urolithin A significantly increased measures of:
- Mitochondrial biogenesis
- Mitochondrial dynamics
- Maximal mitochondrial ATP production
So saying:
“Urolithin A creates more mitochondria”
would oversimplify the evidence.
Does Urolithin A Increase ATP?
Not consistently.
The older-adult randomized trial measured:
maximal mitochondrial ATP production
using magnetic resonance spectroscopy.
The study did not find a significant treatment effect on this endpoint.
That is important because it demonstrates why:
better mitochondrial biomarkers
should not automatically be translated into:
more ATP production.
What Is the Connection Between Mitophagy and Muscle Endurance?
One proposed model is:
Aging / cellular stress
↓
Accumulation of dysfunctional mitochondria
↓
Reduced mitochondrial quality
↓
Less efficient muscle energy metabolism
↓
Greater fatigue susceptibility
Urolithin A may influence:
mitophagy-related quality-control pathways.
If mitochondrial quality improves, researchers hypothesize that muscle cells may become more resistant to fatigue.
The human endurance findings are compatible with this hypothesis.
But they do not yet prove the entire causal pathway.
Can Urolithin A Prevent Age-Related Muscle Loss?
Not proven.
Age-related muscle decline is multifactorial.
Major contributors can include:
- Physical inactivity
- Reduced resistance exercise
- Lower protein intake
- Anabolic resistance
- Neuromuscular changes
- Chronic disease
- Hormonal changes
- Inflammation
- Mitochondrial dysfunction
Urolithin A addresses only one proposed part of this biology.
It should not be viewed as a substitute for:
- Resistance training
- Adequate protein
- Adequate calories
- Physical activity
What Is Sarcopenia?
Sarcopenia is an age-associated muscle disorder involving declines in:
- Muscle strength
- Muscle quantity or quality
- Physical performance
depending on the diagnostic framework used.
It can increase the risk of:
- Falls
- Disability
- Loss of independence
Sarcopenia is not simply:
“getting smaller muscles as you age.”
It is a clinically relevant condition.
Does Urolithin A Treat Sarcopenia?
No.
Urolithin A is not an established treatment for sarcopenia.
The 2026 systematic review included only:
five small randomized trials
with heterogeneous populations.
That evidence is not sufficient to recommend Urolithin A as a sarcopenia therapy.
People concerned about significant muscle loss or weakness should seek appropriate clinical evaluation.
Urolithin A After 50
Interest in muscle preservation often increases after 50.
But age 50 is not a biological switch.
The more important question is whether someone is experiencing:
- Declining strength
- Lower activity
- Reduced muscle mass
- Poor protein intake
- Reduced mobility
Urolithin A may be scientifically interesting in this context.
But it remains an:
adjunctive research-based supplement
rather than a foundation of muscle preservation.
For a broader strategy:
How to Maintain Muscle Mass After 50
Urolithin A After 60
The evidence becomes particularly relevant because one major trial directly studied adults aged:
65–90.
That trial reported improved muscle endurance after:
1,000 mg/day for four months.
However, it did not demonstrate significant improvement in its primary:
six-minute walk distance
outcome.
So the evidence should be interpreted as:
promising but incomplete.
Urolithin A After 70
The older-adult trial included participants into their:
80s.
That gives us more direct evidence in older populations than exists for many emerging longevity compounds.
But trial participants were relatively healthy.
Results should not automatically be generalized to older adults with:
- Severe frailty
- Advanced sarcopenia
- Major mobility limitations
- Complex chronic disease
Urolithin A and Walking
Walking is excellent for:
- Cardiovascular health
- Mobility
- Daily activity
- Endurance
But walking alone is usually not enough to maximize preservation of muscle strength and mass with aging.
Similarly, a supplement that potentially influences walking endurance does not replace resistance exercise.
For muscle preservation, think of:
walking + resistance training
rather than:
walking vs resistance training.
Urolithin A and Resistance Training
This is an important research gap.
The major Urolithin A trials have not established that Urolithin A significantly enhances:
resistance-training-induced muscle growth.
Therefore we cannot confidently say it:
- Makes resistance training more anabolic
- Builds more muscle than training alone
- Increases hypertrophy
- Accelerates strength gains
This would require dedicated training trials.
Does Urolithin A Improve Recovery?
There is not enough human evidence to establish Urolithin A as a proven:
post-workout recovery supplement.
Mitochondrial mechanisms make the hypothesis interesting.
But recovery involves:
- Muscle damage
- Glycogen
- Protein synthesis
- Sleep
- Hydration
- Inflammation
- Nervous-system fatigue
A mitophagy-related mechanism does not automatically improve every component of recovery.
Urolithin A for Athletes
Current evidence is not primarily based on trained athletes.
Major trials have involved populations such as:
- Sedentary older adults
- Untrained middle-aged adults
Therefore results should not automatically be extrapolated to:
- Competitive athletes
- Bodybuilders
- Endurance athletes
- Highly trained individuals
Athletic-performance claims require athlete-specific evidence.
Urolithin A for Bodybuilding
There is currently no strong evidence supporting Urolithin A as a bodybuilding supplement for:
- Hypertrophy
- Muscle protein synthesis
- Maximum strength
- Lean mass gain
It should not be positioned as an alternative to:
- Resistance training
- Adequate protein
- Creatine
- Appropriate energy intake
Does Urolithin A Affect Muscle Protein Synthesis?
This has not been established as a major human mechanism.
Urolithin A research focuses more heavily on:
mitochondrial quality control
than:
direct stimulation of muscle protein synthesis.
That distinction separates it from nutritional strategies centered around:
- Essential amino acids
- Leucine
- Dietary protein
Protein vs Urolithin A for Muscle Aging
These are not substitutes.
Protein
Provides:
amino acids required to build and maintain muscle proteins.
Urolithin A
Is being studied around:
mitochondrial quality control and muscle function.
If dietary protein is inadequate, Urolithin A cannot replace the missing amino acids.
Creatine vs Urolithin A for Healthy Muscle Aging
This comparison is useful because the evidence bases are very different.
|
Creatine |
Urolithin A |
|
|---|---|---|
|
Strength evidence |
Strong |
Emerging |
|
Lean mass evidence |
Moderate–strong with resistance training |
Not established |
|
Muscle endurance |
Some evidence |
Promising |
|
Mitophagy |
Not primary mechanism |
Primary research area |
|
Mitochondrial biomarkers |
Secondary |
Major research area |
|
Older-adult RCTs |
Extensive |
Growing |
|
Direct muscle building |
Can support training adaptations |
Not established |
The compounds answer different biological questions.
Urolithin A vs NMN for Muscle Health
This is another useful distinction.
NMN
Primarily targets:
NAD+ metabolism.
Urolithin A
Primarily targets research around:
mitophagy and mitochondrial quality control.
When the specific question is:
Which currently has more direct human research on muscle endurance?
Urolithin A has a more focused clinical literature in this area.
But neither should replace:
- Resistance exercise
- Protein
- Overall nutrition
For the broader comparison:
NMN vs Urolithin A: Which Is Better for Healthy Aging?
Can You Take Urolithin A With Creatine?
There is no strong evidence establishing an inherent incompatibility.
Mechanistically they are very different.
But there is also insufficient human research showing that combining them produces:
synergistic muscle benefits.
Therefore:
different mechanisms ≠ proven synergy.
Can You Take Urolithin A With NMN?
The same principle applies.
Combining:
- NAD+ support
- Mitophagy-related biology
is mechanistically interesting.
But strong human trials demonstrating superior combined outcomes are lacking.
Read:
Can You Take NMN and Urolithin A Together?
How Much Urolithin A Was Used in Muscle Studies?
Major human trials have studied doses including:
- 500 mg/day
- 1,000 mg/day
The middle-aged trial compared:
500 mg and 1,000 mg daily
for four months.
The older-adult trial used:
1,000 mg daily
for four months.
These are:
research doses.
They should not automatically be interpreted as individualized recommendations.
For the full dose discussion:
Does 1,000 mg Work Better Than 500 mg?
Not consistently enough to establish a universal dose-response rule.
Some outcomes differed by dose in the middle-aged trial.
But the evidence does not support a simple rule that:
twice the dose = twice the muscle benefit.
Clinical response is more complicated than that.
How Long Was Urolithin A Used in Muscle Trials?
Several important trials lasted:
four months.
The older-adult study measured muscle endurance at:
- Two months
- Four months
This gives us useful medium-term information.
But it does not establish:
- Multi-year benefits
- Lifelong effects
- Long-term preservation of muscle mass
How Long Does Urolithin A Take to Affect Muscle?
There is no universal timeline.
In the older-adult trial, some endurance improvements appeared after:
two months.
But this does not mean everyone will:
- Feel stronger after eight weeks
- Walk farther after eight weeks
- Build muscle after eight weeks
Clinical outcomes vary.
Is Urolithin A Safe for Muscle Health Use?
Human trials have generally reported favorable short-term tolerability at studied doses.
The major randomized trials did not identify a clear increase in serious supplement-related safety problems.
However:
- Most studies were small.
- Most lasted only a few months.
- Long-term safety remains less established.
For the complete safety analysis:
Urolithin A Side Effects: Is It Safe to Take Daily?
An Important Conflict-of-Interest Consideration
Several foundational Urolithin A trials were:
- Sponsored by Amazentis SA
- Conducted with involvement from company employees or advisors
Amazentis developed the commercial Urolithin A ingredient used in several studies.
This does not invalidate the trials.
Randomized, placebo-controlled, peer-reviewed industry research can provide valuable evidence.
But funding relationships should be disclosed.
Independent replication is especially important when:
- Study populations are small
- Multiple secondary outcomes are measured
- Commercial interests exist
The new 2026 independent systematic review is therefore particularly valuable because it evaluates the RCT evidence collectively rather than relying on the interpretation of one individual trial.
What the 2026 Meta-Analysis Changes
Before 2026, it was easy to look at individual trials and conclude:
“Urolithin A improves muscle function.”
The new systematic review forces a more precise conclusion.
Across all randomized evidence:
Six-Minute Walk
Directionally favorable but statistically inconclusive.
Muscle Strength
Promising signals, not consistently reproduced.
Muscle Endurance
Positive findings in selected trials.
Aerobic Capacity
Exploratory.
Mitochondrial Biomarkers
Biological activity supported, but clinical meaning remains uncertain.
Overall Certainty
Still limited.
This is exactly how scientific evidence should evolve.
What Urolithin A Has Not Been Proven to Do
Current human evidence does not establish that Urolithin A:
- Builds muscle
- Prevents sarcopenia
- Treats sarcopenia
- Reverses muscle aging
- Replaces resistance training
- Replaces protein
- Dramatically increases ATP
- Improves athletic performance in trained athletes
- Extends human lifespan
- Reverses biological age
These claims should not be inferred from mitochondrial mechanisms alone.
What Has Actually Been Demonstrated?
A reasonable 2026 evidence hierarchy looks like this:
Better Supported
Biological Activity
Oral Urolithin A is bioavailable and changes selected mitochondrial-related biomarkers.
Short-Term Tolerability
Generally favorable in published human trials.
Promising
Muscle Endurance
Positive findings have been reported, particularly in older adults.
Selected Muscle-Strength Measures
Positive findings have appeared in middle-aged adults.
Uncertain
Walking Capacity
Pooled evidence favors Urolithin A but remains statistically inconclusive.
Aerobic Capacity
Interesting signals but insufficient replication.
Overall Physical Performance
Not consistently improved.
Not Established
Muscle Hypertrophy
Sarcopenia Treatment
Athletic Performance Enhancement
Prevention of Age-Related Muscle Loss
Human Longevity
What Actually Works Best for Maintaining Muscle With Age?
The strongest strategy is still not a supplement.
It is a system.
1. Resistance Training
Probably the most important modifiable intervention for preserving:
- Strength
- Muscle function
- Physical independence
2. Adequate Protein
Older adults need sufficient dietary protein to support:
- Muscle protein synthesis
- Recovery
- Tissue maintenance
3. Adequate Calories
Chronic under-eating can accelerate muscle loss.
4. Regular Physical Activity
Including:
- Walking
- Aerobic activity
- Daily movement
5. Sleep
Poor sleep can negatively influence:
- Recovery
- Hormonal regulation
- Training quality
6. Address Medical Causes of Muscle Loss
Including:
- Chronic disease
- Malnutrition
- Medication effects
- Hormonal disorders
- Neurological disease
Urolithin A should be viewed as:
a potential adjunct to these foundations
rather than:
a replacement for them.
Where Urolithin A May Fit
A reasonable model is:
Resistance Training
Adequate Protein
Adequate Energy
Regular Physical Activity
Sleep & Recovery
↓
Foundation for Healthy Muscle Aging
Then, potentially:
Urolithin A
↓
Adjunct targeting mitochondrial quality-control biology
That is a much more scientifically defensible positioning.
Who Might Be Most Interested in Urolithin A Research?
Based on current studies, the research may be especially relevant to adults interested in:
- Healthy muscle aging
- Mitochondrial health
- Muscle endurance
- Maintaining physical function with age
But current evidence does not allow us to identify a precise subgroup that is guaranteed to benefit.
The Bottom Line
Urolithin A is one of the more scientifically interesting compounds currently being studied at the intersection of:
mitochondrial health and muscle aging.
Human randomized trials have reported promising findings involving:
- Muscle endurance
- Selected strength measures
- Mitochondrial biomarkers
But the newest evidence changes how confidently those findings should be described.
A 2026 systematic review and meta-analysis identified:
five randomized controlled trials involving 236 participants.
For the only outcome that could be quantitatively pooled—the six-minute walk test—the estimated effect favored Urolithin A by:
17.03 meters.
But the result was:
not statistically significant
and the certainty of evidence was:
low.
Other findings involving:
- Strength
- Endurance
- Aerobic capacity
- Mitochondrial biomarkers
remain promising but heterogeneous.
So the most accurate conclusion in 2026 is:
Urolithin A shows promising human signals for muscle endurance and mitochondrial biology, but current evidence is not strong enough to conclude that it builds muscle, prevents sarcopenia or consistently improves overall physical performance.
That does not make the research unimportant.
It tells us exactly where the science stands.
For healthy muscle aging, the hierarchy remains clear:
resistance training, adequate protein, adequate nutrition and regular physical activity come first.
Urolithin A is better viewed as:
an emerging mitochondrial-health adjunct being actively studied for muscle function
rather than:
a proven muscle-building treatment.
Frequently Asked Questions
Is Urolithin A good for muscle health?
Human trials have reported promising findings involving muscle endurance, selected strength outcomes and mitochondrial biomarkers. However, the total evidence remains limited and inconsistent across outcomes.
Does Urolithin A build muscle?
There is currently insufficient human evidence showing that Urolithin A directly increases muscle mass or hypertrophy.
Does Urolithin A increase muscle strength?
One middle-aged-adult trial reported improvements in selected muscle-strength outcomes, but the 2026 systematic review considers strength evidence exploratory rather than consistently reproduced.
Does Urolithin A improve muscle endurance?
A randomized trial in adults aged 65–90 reported improvements in hand and leg muscle endurance compared with placebo.
Does Urolithin A improve walking?
The 2026 meta-analysis estimated approximately 17 meters greater improvement in six-minute walking distance, but the result was not statistically significant and evidence certainty was low.
Does Urolithin A help sarcopenia?
Urolithin A is not an established treatment for sarcopenia.
Does Urolithin A increase mitochondria?
Urolithin A affects mitochondrial-related pathways and biomarkers, but it should not simply be described as creating more mitochondria.
Does Urolithin A increase ATP?
A randomized older-adult trial did not demonstrate a significant improvement in maximal mitochondrial ATP production.
Is Urolithin A good after age 50?
It is scientifically interesting for healthy muscle aging, but resistance training, protein intake and overall nutrition have substantially stronger evidence.
Is Urolithin A good after 60?
Older adults have been directly studied, including adults aged 65–90. Selected endurance outcomes improved, but overall functional evidence remains incomplete.
Is Urolithin A better than creatine for muscle?
Current evidence does not support that conclusion. Creatine has a much larger evidence base for strength and resistance-training-related lean mass outcomes.
Can you take Urolithin A with creatine?
No major incompatibility has been established, but strong human evidence showing synergistic muscle benefits from the combination is lacking.
Can you take Urolithin A with NMN?
The compounds affect different biological pathways, but superior combined benefits have not been established in high-quality human trials.
How much Urolithin A was used in muscle studies?
Major human trials have used 500 mg/day and 1,000 mg/day. These are research doses, not individualized recommendations.
How long does Urolithin A take to work for muscle?
Some endurance differences appeared after approximately two months in an older-adult trial, but there is no universal timeline.
Related Celnovix Guides
- What Is Urolithin A?
- Urolithin A Benefits
- Urolithin A Side Effects
- Urolithin A Dosage Guide
- Best Time to Take Urolithin A
- Foods Rich in Urolithin A
- NMN vs Urolithin A
- Urolithin A vs CoQ10
- Urolithin A vs Resveratrol
- Can You Take NMN and Urolithin A Together?
- Creatine for Healthy Muscle Aging
- How to Maintain Muscle Mass After 50
References
Dao T, Nguyen TT, Gariani K, Kim HJ, Ryu D.
Effects of Urolithin A Supplementation on Muscle Health Outcomes in Humans From Randomized Controlled Trials
Published in 2026, this systematic review and meta-analysis included:
5 randomized controlled trials and 236 participants.
The pooled six-minute walk estimate favored Urolithin A by:
17.03 meters
but was not statistically significant:
95% CI −5.33 to 39.40; P = 0.135.
GRADE certainty was rated:
low.
Other muscle and mitochondrial outcomes were considered exploratory because of heterogeneity and limited replication.
View the 2026 systematic review on PubMed
Liu S, et al.
Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial
Published in JAMA Network Open, this randomized trial included:
66 adults aged 65–90.
Participants received:
1,000 mg/day Urolithin A
or placebo for four months.
Urolithin A improved selected hand and leg muscle-endurance measures.
The primary six-minute walk outcome and maximal mitochondrial ATP-production outcome were not significantly improved.
Singh A, et al.
Urolithin A Improves Muscle Strength, Exercise Performance, and Biomarkers of Mitochondrial Health in a Randomized Trial in Middle-Aged Adults
This randomized trial included:
88 untrained, overweight middle-aged adults.
Participants received:
- Placebo
- 500 mg/day Urolithin A
- 1,000 mg/day Urolithin A
for four months.
Selected muscle-strength, exercise and mitochondrial outcomes favored Urolithin A.
However:
the primary peak-power endpoint was not significantly improved.
The study was sponsored by Amazentis SA, and several authors disclosed relationships with the company.
Andreux PA, et al.
The Mitophagy Activator Urolithin A Is Safe and Induces a Molecular Signature of Improved Mitochondrial and Cellular Health in Humans
This first-in-human study evaluated Urolithin A in healthy sedentary older adults.
Four weeks of:
- 500 mg/day
- 1,000 mg/day
altered plasma acylcarnitines and skeletal-muscle mitochondrial gene expression.
The findings established human bioavailability and biological activity but did not establish broad clinical muscle benefits.
Evidence Transparency
Important limitations of the current Urolithin A muscle literature include:
- Only a small number of randomized trials
- Approximately 236 participants in the latest systematic review
- Relatively short intervention periods
- Heterogeneous populations
- Different doses
- Different muscle-performance tests
- Different mitochondrial biomarkers
- Industry involvement in several foundational trials
- Limited independent replication
- Few outcomes suitable for quantitative meta-analysis
For these reasons, Celnovix does not interpret current evidence as proof that Urolithin A:
- Builds muscle
- Prevents sarcopenia
- Reverses muscle aging
- Replaces exercise
Editorial Standards
Celnovix prioritizes:
- Human randomized controlled trials
- Systematic reviews and meta-analyses
- Primary outcomes over selective secondary outcomes
- Statistical significance and confidence intervals
- Evidence-certainty frameworks such as GRADE
- Transparent disclosure of study limitations and industry involvement
We distinguish between:
mechanistic evidence
biomarker changes
functional outcomes
and:
proven clinical benefit.
These are not interchangeable.
Medical Disclaimer
This article is provided for general educational and informational purposes only and does not constitute medical advice, diagnosis or treatment.
Urolithin A is not established as a treatment for sarcopenia, muscle wasting, frailty or other medical conditions.
Clinical-study doses are included to explain published research and should not automatically be interpreted as individualized dosage recommendations.
If you have unexplained muscle weakness, rapid muscle loss, frailty, significant chronic disease, are pregnant or breastfeeding, or take prescription medications, discuss supplement use and muscle-health concerns with an appropriately qualified healthcare professional.
